… metastatic renal cell carcinoma. We did a phase III, randomised, double-blind, placebo-controlled
trial of everolimus in patients with metastatic renal cell carcinoma whose disease had …

… a phase 3 randomised trial of patients of any age with newly diagnosed, histologically
confirmed, squamous cell carcinoma of … This study is registered at controlled-trials.com, ISRCTN …

… We did this open-label, phase 3 randomised controlled trial at 183 cancer centres in 23
countries worldwide. We enrolled adults with stage IIIB or IV squamous cell carcinoma of the …

… In the phase 3, randomised, controlled CheckMate 214 trial, … confirmed renal cell carcinoma
with a clear-cell component … Metastatic Renal Cell Carcinoma Database Consortium risk …

… -controlled phase 2 study (BERIL-1), we recruited patients aged 18 years and older with
histologically or cytologically confirmed recurrent and metastatic squamous cell carcinoma of …

… The options for first-line treatment of advanced oesophageal squamous cell carcinoma are
… patients with advanced oesophageal squamous cell carcinoma. We report interim analysis …

… metastatic renal cell carcinoma (… controlled trial for telaglenastat, data from this study
demonstrate proof-of-concept for telaglenastat in RCC, while building on findings from the phase …

… subsequent innate and adaptive cell‐mediated immune response. Clinical studies have
demonstrated clinical and histological clearance of superficial basal cell carcinoma (sBCC) after …

… Organ-confined renal-cell carcinoma is associated with tumour progression in … cell vaccine
on risk of tumour progression in patients with stage pT2–3b pN0–3 M0 renal-cell carcinoma…

BACKGROUND: Recurrence prophylaxis with intravesical gemcitabine (GEM) was effective
and safe in patients with non-muscle-invasive bladder cancer (NMIBC); efficacy as single-…